Impact of nirsevimab on respiratory syncytial virus bronchiolitis in hospitalized infants: a real-world study.
Résumé
Regarding nirsevimab immunization status, among 1085 infants hospitalized for bronchiolitis, the odds of hospitalization for respiratory syncytial virus bronchiolitis were 4.7 times higher for nonimmunized children. Immunized infants were less likely to require oxygen supplementation (20.2% vs. 30.6%, P = 0.02) and had a 1-day shorter hospital stay. Respiratory syncytial virus bronchiolitis was less frequent and less severe in infants immunized with nirsevimab.
Domaines
Sciences du Vivant [q-bio]
Fichier principal
impact_of_nirsevimab_on_respiratory_syncytial.1098.pdf (506.17 Ko)
Télécharger le fichier
Origine | Fichiers produits par l'(les) auteur(s) |
---|